Next-generation sequencing (NGS) has increased the speed, scale, throughput, and accessibility of sequencing, greatly accelerating genomic research. This progress has been aided by the development of ...

Patient-reported outcomes in GI cancer: Leading change to meet the needs of the gastrointestinal cancer community. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...

The webinar series titled "The Basics of Next Generation Sequencing and its Application in Precision Oncology" aims to provide a comprehensive understanding of the fundamentals and practical ...

The Advances in Genome Biology and Technology (AGBT) meeting celebrated its 25 th anniversary in sunny Marco Island, Florida, with the customary mix of big name speakers addressing researchers and ...

This eBook explores next-generation sequencing (NGS) methods and their applications in neurological and cancer research, with key content from BioTechniques’ digital hub and Taylor & Francis journals, ...

Advances in next-generation sequencing (NGS) have propelled genomics research to new heights. With the introduction of new sequencing platforms such as Element Biosciences’ AVITI and Ultima Genomics’ ...

SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next ...

Integrative oncology interest in persons with a cancer diagnosis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.

The Global DNA Sequencing Market was valued at USD 14.8 Billion in 2024, and is expected to reach USD 34.8 Billion by 2029, rising at a CAGR of 18.60%. The report highlights the current and future ...

Please provide your email address to receive an email when new articles are posted on . Real-world data show that only about 30% to 40% of patients with the most common cancers receive NGS testing.